EVALUATION OF IN VITRO ANTI UROLITHIATIC ACTIVITY OF SENNA OCCIDENTALIS
Journal Title: Indo American Journal of Pharmaceutical Sciences - Year 2018, Vol 5, Issue 3
Abstract
The present study was explores that evaluation of in vitro antiurolithiatic activity of Senna occidentalis. It was observed that thehighest calcium oxalate crystals dissolution was observed in the ethanolic extract of Senna occidentalis. It was found that ethanolic extract of Senna occidentalis has more efficient to dissolve calciumoxalate. In this study Neeri was used as standard drug. Key words: Senna Occidentalis, urolithiasis and Ethanolic extract
Authors and Affiliations
Keywords
Related Articles
- EP ID EP277147
- DOI -
- Views 288
- Downloads 0
REGULATORY REQUIREMENTS FOR APPROVAL FASTTRACK DRUGS AS PER US GUIDELINES
Fast track is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need. AIDS, Alzheimer’s, heart failure and cancer are obvious examples...
DESIGN AND CHARATERZATION OF ETHOSOME DRUG DELIVERY SYSTEM CONTAINING ISRADIPINE FOR TOPICAL APPLICATION
The increasing demand for efficient administration and delivery of Pharmaceutical dosage forms possessing the attributes namely minimum side effects, improved patient compliance has resulted in the formulation of novel d...
FORMULATION, OPTIMIZATION AND EVALUATION COLON TARGATED DRUG DELIVERY SYSTEM FOR ORNIADAZOLE
The colon is a site where both local and systemic delivery of drugs can take place. The present investigation concerns with formulation and evaluation of Colon Targeted dip coated tablets of Ornidazole by using HPMCK4 M,...
REVIEW ON SPRAY DRIED SOLID DISPERSION
The drug solubility is the most challenging aspect for the formulation development. The poorly soluble drug has poor dissolution and absorption of drug. The low aqueous solubility of drug is required to formulate the dru...
ASSESSMENT OF KNOWLEDGE OF STUDENTS AT PUNJAB UNIVERSITY CAMPUS GUJRANWALA REGARDING FACTORS CONTRIBUTING FOR HEPATITIS C
Hepatitis C Virus (HCV) is affecting 170 million people annually (WHO, 2012) and Pakistan ranks high in chronic hepatitis. HCV is a leading cause of chronic liver disease and hepatocellular carcinoma rapidly transmitting...